We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




2012 Best Year for Health IT Venture Capital Funding Ever

By HospiMedica International staff writers
Posted on 11 Feb 2013
Health IT venture capital (VC) funding in 2012 approached USD 1.2 billion, dwarfing the 480 million given in 2011, and the 211 million in 2010. More...
These are the latest results reported by Mercom Capital Group (Austin, TX, USA), a healthcare information communications, and consulting firm.

The year 2012 concluded with 163 deals. The top five VC funding deals included 100 million raised by Castlight Health, which develops technology to enable comparisons of doctors, hospitals, and medical procedures based on price and quality; 58 million raised by 23andMe, a personal genetics company; 50 million raised by GoHealth, an online portal that helps compare health insurance coverage; 40 million raised by Kinnser Software, which provides clinical support to home health companies; and 34 million raised by Practice Fusion, which develops a free Web-based electronic medical record (EMR).

According to the report, the top investors that participated in VC funding rounds in 2012 were Connecticut Innovations, Founders Fund, Merck Global Health Innovation Fund, Qualcomm, and West Health Investment Fund (all with four deals each). Other notable investors included Aberdare Ventures, Canaan Partners, First Round Capital, and Khosla Ventures, with three deals apiece. In addition, although there was some overlap, slightly more funding in 2012 went towards consumer centric companies (582 million) than to companies focusing on health practice-centric technologies (591 million).

“While the focus of funding has been in the health information management category, which covers technologies on the healthcare practice side, there is significant investment and funding going into companies that engage the consumers – like mobile health, telehealth, personal health and social health,” said Raj Prabhu, managing partner of Mercom Capital Group.

Related Links:

Mercom Capital Group




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.